← FDATracker
HomeAdverse Events

FTY 720 Adverse Event: Basal cell carcinoma

FTY 720 Adverse Event: Basal cell carcinoma is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: FTY 720; Product category: Drug; Primary reaction: Basal cell carcinoma.

Primary drugFTY 720
Product categoryDrug
Primary reactionBasal cell carcinoma
All reactionsBasal cell carcinoma
SeriousnessSerious
Patient outcomeRecovered/Resolved
Patient sexMale
All drugs reportedFTY 720; STILNOX; VITAMIN D
Reporter countryAU
Reporter type3
Report date20140312
Report ID10005444

🔍 Search all adverse events →